![Antonin Rollet de Fougerolles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonin Rollet de Fougerolles
Director/Board Member at
DEEPMATTER GROUP PLC
Profile
Antonin Rollet de Fougerolles is currently the Chairman at eTheRNA immunotherapies NV.
He is also a Director at Chimeron Bio Corp., Walking Fish Therapeutics, Inc., and a Non-Executive Director at ChemAI Ltd. Previously, he served as the Chief Executive Officer & Director at Evox Therapeutics Ltd. from 2018 to 2024.
He was the Chief Scientific Officer at Tolerx, Inc. in 2010-2011 and at Ablynx NV from 2013 to 2018.
Additionally, he held the position of VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc. from 2009 to 2010.
Dr. de Fougerolles obtained a doctorate degree from Harvard University.
Antonin Rollet de Fougerolles active positions
| Companies | Position | Start |
|---|---|---|
| DEEPMATTER GROUP PLC | Director/Board Member | 27/11/2024 |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Director/Board Member | - |
Chimeron Bio Corp.
 Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Director/Board Member | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Chairman | 10/07/2024 |
Former positions of Antonin Rollet de Fougerolles
| Companies | Position | End |
|---|---|---|
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Chief Executive Officer | 29/04/2024 |
| ABLYNX | Chief Tech/Sci/R&D Officer | 01/02/2018 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Chief Tech/Sci/R&D Officer | 19/12/2011 |
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Chief Tech/Sci/R&D Officer | - |
Training of Antonin Rollet de Fougerolles
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Develops transformational therapeutics | Health Technology |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Develops personalized immuno therapeutics for the treatment of cancer | Health Technology |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics to treat diseases | Health Technology |
- Stock Market
- Insiders
- Antonin Rollet de Fougerolles
